Evidence map›Paper›PMID 38717555›Full record

ArticlePharmacoEconomics - open2024

Correction: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension.

Rod S Taylor, Anthony Bentley, Kaylie Metcalfe, Melvin D Lobo, Ajay J Kirtane, Michel Azizi, Christopher Clark, Kieran Murphy, Jennifer H Boer, Marjolijn van Keep and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in PharmacoEconomics - open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Rod S TaylorMRC/CSO Social and Public Health Sciences Unit and Robertson Centre for Biostatistics, Institute of Health and Well Being, University of Glasgow, 90 Byres Rd, Glasgow, G12 8TB, UK. rod.taylor@glasgow.ac.uk.ORCID http://orcid.org/0000-0002-3043-6011
Anthony BentleyMtech Access Limited, Bicester, Oxfordshire, UK.
Kaylie MetcalfeMtech Access Limited, Bicester, Oxfordshire, UK.
Melvin D LoboBarts NIHR Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London, UK.
Ajay J KirtaneColumbia University Irving Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA.
Michel AziziUniversité de Paris, Paris, France.
Christopher ClarkPrimary Care Research Group, University of Exeter Medical School, Exeter, UK.
Kieran MurphyReCor Medical, Palo Alto, CA, USA.
Jennifer H BoerBresMed Netherlands, Utrecht, The Netherlands.
Marjolijn van KeepBresMed Netherlands, Utrecht, The Netherlands.
An Thu TaBresMed Netherlands, Utrecht, The Netherlands.
Neil C BarmanReCor Medical, Palo Alto, CA, USA.
Garrett SchwabReCor Medical, Palo Alto, CA, USA.
Ron AkehurstBresMed Health Solutions, Sheffield, UK.
Roland E SchmiederNephrology and Hypertension, University Hospital Erlangen, Friedrich Alexander University, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38717555
PMCPMC11252093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.